Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
304 studies found for:    APLASTIC ANEMIA
Show Display Options
Rank Status Study
1 Recruiting Study of Romiplostim(AMG531) in Subjects With Aplastic Anemia
Condition: Aplastic Anemia
Intervention: Biological: Romiplostim
2 Recruiting Safety and Efficacy of Exjade in the Treatment of Transfusion-dependent Iron Overload in Aplastic Anemia Patients
Condition: Aplastic Anemia
Interventions: Drug: ICL670A and standard immunosupressive therapy (Cyclosporine A);   Drug: Immunosupressive therapy (Cyclosporine A)
3 Unknown  Comparison of Cy-Atg vs Flu-Atg for the Conditioning Therapy in Allo-HCT for Adult Aplastic Anemia
Condition: Aplastic Anemia
Interventions: Drug: Cy-ATG;   Drug: Flu-ATG
4 Completed Mesenchymal Stem Cells in the Treatment of Relapsed/Refractory Severe Acquired Aplastic Anemia
Condition: Aplastic Anemia
Intervention: Biological: Intravenous bone marrow mesenchymal stem cells infusion
5 Terminated
Has Results
Allogeneic Stem Cell Transplant for Patients With Severe Aplastic Anemia
Condition: Aplastic Anemia
Interventions: Drug: Cytoxan;   Drug: Campath;   Radiation: Total Body Irradiation (TBI);   Drug: FK-506;   Drug: Methotrexate;   Procedure: Stem cell infusion
6 Unknown  Study of Fludarabine + Cyclophosphamide + TBI Conditioning Regimen for Double Units Cord Blood Transplantation(CBT)in Severe Aplastic Anemia(SAA)
Condition: Aplastic Anemia
Intervention: Other: Cyclophosphosphamide, TBI
7 Suspended Alefacept in Patients With Relapsed/Refractory Aplastic Anemia
Condition: Aplastic Anemia
Intervention: Drug: Alefacept
8 Withdrawn Alemtuzumab and Rituximab in Aplastic Anemia
Condition: Aplastic Anemia
Intervention: Drug: Alemtuzumab and Rituximab
9 Unknown  Moderate-dose Cyclophosphamide for Childhood Acquired Aplastic Anemia
Condition: Aplastic Anemia
Intervention: Drug: cyclophosphamide,cyclosporine A
10 Terminated Randomized Study In Severe Aplastic Anemia Patients Receiving Atg, Cyclosporin A, With Or Without G-CSF (SAA-G-CSF)
Condition: Aplastic Anaemia
Interventions: Drug: G-CSF;   Drug: Early retreatment with ATG
11 Completed Neuropsychological Effects of Immunosuppressive Treatment in Subjects With Aplastic Anemia
Condition: Aplastic Anemia
Intervention:
12 Completed Combination Therapy of Severe Aplastic Anemia
Condition: Severe Aplastic Anemia
Intervention: Drug: Cyclosporine
13 Recruiting Comparison of Two Different Doses of Rabbit ATG-Fresenius With Cyclosporin in the Treatment of Acquired Aplastic Anaemia
Condition: Aplastic Anemia
Intervention: Drug: ATG-fresenius
14 Completed Improving Immunosuppressive Treatment for Patients With Severe Aplastic Anemia
Condition: Aplastic Anemia
Intervention: Drug: Sirolimus (Rapamune)
15 Completed Human Leukocyte Antigen (HLA)-Haploidentical Hematopoietic Stem Cell Transplantation for Patients With Aplastic Anemia
Condition: Aplastic Anemia
Interventions: Biological: anti-thymocyte globulin;   Biological: filgrastim;   Drug: Fludarabine;   Drug: Cyclophosphamide;   Procedure: CD3±CD19 depleted hematopoietic stem cell transplantation
16 Unknown  Rabbit Antithymocyte Globulin (Thymoglobuline) With Ciclosporin for Patients With Acquired Aplastic Anaemia
Condition: Aplastic Anemia
Intervention: Drug: rabbit antithymocyte globulin
17 Recruiting Safety and Efficacy of Patient's Own AD-MSC and AD-HSC Transplantation in Patients With Severe Aplastic Anemia
Condition: Severe Aplastic Anemia
Interventions: Drug: Rabbit antithymoglobulin (ATG);   Procedure: Adipose derived mesenchymal stem cells ( AD-MSCs);   Procedure: AD-MSC transdifferentiated HSCs (AD-HSCs)
18 Completed Oral Manifestations of Aplastic Anemia
Condition: Aplastic Anemia
Intervention:
19 Completed Collection of Biological Samples From Patients With Hepatitis-Associated Aplastic Anemia
Condition: Aplastic Anemia
Intervention:
20 Recruiting The Efficacy of Immunosuppressive Therapy Combined With Cord Blood Transfusion in Treatment of Severe Aplastic Anemia
Condition: Severe Aplastic Anemia
Interventions: Procedure: IST;   Biological: cord blood transfusion;   Drug: Thymoglobuline® and oral CSA

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.